Montelukast in children with allergic rhinitis amid COVID‐19 pandemic

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetter

Abstract

We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.
Original languageEnglish
Pages (from-to)2151
Number of pages1
JournalActa Paediatrica, International Journal of Paediatrics
Volume109
Issue number10
Early online date19 Jul 2020
DOIs
Publication statusPublished - 1 Oct 2020

Fingerprint Dive into the research topics of 'Montelukast in children with allergic rhinitis amid COVID‐19 pandemic'. Together they form a unique fingerprint.

  • Cite this